MONOPTEROS THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://monopterostx.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Phase 1
- Conditions
- Solid Tumor, AdultAdvanced Solid TumorAdvanced CancerMetastatic CancerRefractory Cancer
- Interventions
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Monopteros Therapeutics Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT04859777
- Locations
- 🇺🇸
St. John's Cancer Center, Santa Monica, California, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Columbia University, New York, New York, United States
News
No news found